Skip to main content

Table 1 Characteristics and clinical data of patients (n = 40)

From: Efficacy of early goal-directed therapy using FloTrac/EV1000 to improve postoperative outcomes in patients undergoing off-pump coronary artery bypass surgery: a randomized controlled trial

Variable

EV1000 (n = 20)

Control (n = 20)

P-value

Age (y)

68.1 ± 5.7

65.1 ± 9.3

0.226

Sex: male

14 (70)

16 (80)

0.328

Height (cm)

163.2 ± 7.1

161.1 ± 7.3

0.328

Weight (kg)

64.3 ± 12.2

70.0 ± 11.8

0.140

Number of vessel anastomosis

  

0.101

 2

2 (10)

1 (5)

 

 3

11 (55)

7 (35)

 

 4

7 (35)

7 (35)

 

 5

0 (0)

5 (25)

 

Functional class

  

0.128

 2

8 (40)

14 (70)

 

 3

11 (55)

6 (30)

 

 4

1 (5)

0 (0)

 

ASA classification

  

0.116

 2

2 (10)

7 (35)

 

 3

17 (85)

13 (65)

 

 4

1 (5)

0 (0)

 

Ejection fraction (%)

59.3 ± 6.6

63.3 ± 13.8

0.253

Anesthesia time (min)

309.8 ± 72.6

301.5 ± 42.7

0.664

Crystalloid intake (mL/h)

572.0 ± 72.3

427.3 ± 232.4

0.014

Blood loss (mL)

680.0 ± 392.2

665.0 ± 253.4

0.887

Urine output (mL/h)

104.2 ± 23.3

65.0 ± 52.0

0.005

  1. Data are expressed as mean ± SD or number (%)
  2. ASA American Society of Anesthesiologists; CKD chronic kidney disease; INR international normalized ratio; CPB cardiopulmonary bypass